Search Results - "Laranjeira, A B A"

Refine Results
  1. 1

    DNA damage, demethylation and anticancer activity of DNA methyltransferase (DNMT) inhibitors by Laranjeira, Angelo B. A., Hollingshead, Melinda G., Nguyen, Dat, Kinders, Robert J., Doroshow, James H., Yang, Sherry X.

    Published in Scientific reports (12-04-2023)
    “…Role of DNA damage and demethylation on anticancer activity of DNA methyltransferase inhibitors (DNMTi) remains undefined. We report the effects of DNMT1 gene…”
    Get full text
    Journal Article
  2. 2

    IL-7 Contributes to the Progression of Human T-cell Acute Lymphoblastic Leukemias by SILVA, Ana, LARANJEIRA, Angelo B. A, MARTINS, Leila R, CARDOSO, Bruno A, DEMENGEOT, Jocelyne, ANDRES YUNES, J, SEDDON, Benedict, BARATA, Joao T

    Published in Cancer research (Chicago, Ill.) (15-07-2011)
    “…The importance of microenvironmental factors for driving progression in leukemia has been debated. Previous evidence has pointed to interleukin-7 (IL-7), a…”
    Get full text
    Journal Article
  3. 3

    Upregulation of TET2 and Resistance to DNA Methyltransferase (DNMT) Inhibitors in DNMT1 -Deleted Cancer Cells by Laranjeira, Angelo B A, Nguyen, Dat, Pelosof, Lorraine C, Doroshow, James H, Yang, Sherry X

    Published in Diseases (01-07-2024)
    “…Ten-eleven-translocation (TET) 2 is a member of the TET family of proteins (TET1-3). gene deletion confers resistance to DNA methyltransferase (DNMT)…”
    Get full text
    Journal Article
  4. 4

    IGFBP7 participates in the reciprocal interaction between acute lymphoblastic leukemia and BM stromal cells and in leukemia resistance to asparaginase by Laranjeira, A B A, de Vasconcellos, J F, Sodek, L, Spago, M C, Fornazim, M C, Tone, L G, Brandalise, S R, Nowill, A E, Yunes, J A

    Published in Leukemia (01-05-2012)
    “…The interaction of acute lymphoblastic leukemia (ALL) blasts with bone marrow (BM) stromal cells (BMSCs) has a positive impact on ALL resistance to…”
    Get full text
    Journal Article
  5. 5
  6. 6

    TAL1 SCL is downregulated upon histone deacetylase inhibition in T-cell acute lymphoblastic leukemia cells by Cardoso, B A, de Almeida, S F, Laranjeira, A B A, Carmo-Fonseca, M, Yunes, J A, Coffer, P J, Barata, J T

    Published in Leukemia (01-10-2011)
    “…The transcription factor T-cell acute lymphocytic leukemia (TAL)-1 is a major T-cell oncogene associated with poor prognosis in T-cell acute lymphoblastic…”
    Get full text
    Journal Article
  7. 7

    Simultaneous detection of lysine metabolites by a single LC–MS/MS method: monitoring lysine degradation in mouse plasma by Pena, Izabella A., Marques, Lygia A., Laranjeira, Angelo B. A., Yunes, José A., Eberlin, Marcos N., Arruda, Paulo

    Published in SpringerPlus (25-02-2016)
    “…Detection and quantification of lysine degradation metabolites in plasma is necessary for the diagnosis and follow-up of diseases such as pyridoxine-dependent…”
    Get full text
    Journal Article
  8. 8

    Low-dose methotrexate in sickle-cell disease: a pilot study with rationale borrowed from rheumatoid arthritis by Brandalise, Silvia R, Assis, Rosemary, Laranjeira, Angelo B A, Yunes, José Andrés, de Campos-Lima, Pedro O

    Published in Experimental hematology & oncology (19-06-2017)
    “…Inflammation is a major feature of sickle cell disease (SCD). Low-dose methotrexate (MTX) has long been used in chronic inflammatory diseases. This pilot study…”
    Get full text
    Journal Article
  9. 9

    In vivo ablation of NF-κB cascade effectors alleviates disease burden in myeloproliferative neoplasms by Laranjeira, Angelo B. A., Kong, Tim, Snyder, Steven C., Fulbright, Mary C., Fisher, Daniel A. C., Starczynowski, Daniel T., Oh, Stephen T.

    Published in Blood (06-06-2024)
    “…•Abrogation of RelA, Myd88, and IRAK4 consistently suppressed disease hallmarks of leukocytosis, splenomegaly, and bone marrow dysfunction.•IRAK4 inhibitor…”
    Get full text
    Journal Article
  10. 10

    Comprehensive profiling of clinical JAK inhibitors in myeloproliferative neoplasms by Kong, Tim, Yu, LaYow, Laranjeira, Angelo B. A., Fisher, Daniel A. C., He, Fan, Cox, Maggie J., Oh, Stephen T.

    Published in American journal of hematology (01-07-2023)
    “…Small molecule inhibitors targeting JAK2 provide symptomatic benefits for myeloproliferative neoplasm (MPN) patients and are among first‐line therapeutic…”
    Get full text
    Journal Article
  11. 11

    Complementary and countervailing actions of Jak2 and Ikk2 in hematopoiesis in mice by Fisher, Daniel A.C., Laranjeira, Angelo B.A., Kong, Tim, Snyder, Steven C., Shim, Kevin, Fulbright, Mary C., Oh, Stephen T.

    Published in Experimental hematology (01-12-2023)
    “…•Jak2 V617F and Ikk2-CA showed distinct and partly opposed effects on hematopoiesis.•Jak2 V617F and Ikk2-CA both antagonized frequency of transplantable…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    DUSP6 mediates resistance to JAK2 inhibition and drives leukemic progression by Kong, Tim, Laranjeira, Angelo B A, Yang, Kangning, Fisher, Daniel A C, Yu, LaYow, Poittevin De La Frégonnière, Laure, Wang, Anthony Z, Ruzinova, Marianna B, Fowles, Jared S, Fulbright, Mary C, Cox, Maggie J, Celik, Hamza, Challen, Grant A, Huang, Sidong, Oh, Stephen T

    Published in Nature cancer (01-01-2023)
    “…Myeloproliferative neoplasms (MPNs) exhibit a propensity for transformation to secondary acute myeloid leukemia (sAML), for which the underlying mechanisms…”
    Get full text
    Journal Article
  15. 15

    Therapeutic target discovery and drug development in cancer stem cells for leukemia and lymphoma: from bench to the clinic by Laranjeira, Angelo B A, Yang, Sherry X

    Published in Expert opinion on drug discovery (01-11-2016)
    “…Cancer stem cells (CSCs), also known as tumor initialing cells, have self-renewal capacity and are believed to play an important role in residual disease or…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Assessment of BCL2/J(H) translocation in healthy individuals exposed to low-level radiation of 137CsCl in Goiânia, Goiás, Brazil by Nunes, H F, Laranjeira, A B A, Yunes, J A, Costa, E O A, de A Melo, C O, de M e Silva, D, da Cruz, A D

    Published in Genetics and molecular research (16-01-2013)
    “…Healthy radio-exposed individuals who received low levels of Cesium-137 radiation during the accident that occurred in Goiânia in 1987, their families and…”
    Get full text
    Journal Article
  18. 18

    In Vivo Ablation of NFκB Cascade Effectors Alleviates Disease Burden in Myeloproliferative Neoplasms by Laranjeira, Angelo B. A., Kong, Tim, Snyder, Steven Craig, Fulbright, Mary C., Fisher, Daniel A.C., Starczynowski, Daniel T., Oh, Stephen T.

    Published in Blood (02-11-2023)
    “…ABAL and TK equal contributors Multilevel regulation of NFκB activation exists in response to microenvironmental cues. Aberrant hyperactivation of the NFκB…”
    Get full text
    Journal Article
  19. 19

    Galectin-1 Fuels Monocyte-Driven Hyperinflammation and Represents a Novel Therapeutic Target in Myeloproliferative Neoplasms by He, Fan, Kong, Tim, Lin, Shuyang, Fulbright, Mary C., Laranjeira, Angelo B. A., Fisher, Daniel A.C., Cox, Maggie J, Ashworth, Katrina, Di Paola, Jorge, Oh, Stephen T.

    Published in Blood (02-11-2023)
    “…JDP and STO co-corresponding authors Previous studies by our group and others have demonstrated that monocytes play a key role in driving hyperinflammation in…”
    Get full text
    Journal Article
  20. 20